BMS, Sanofi Lose Remand Challenge In Plavix MDL
A New Jersey federal judge on Wednesday remanded 57 cases claiming injuries over the blood thinner Plavix despite arguments from Bristol-Meyers Squibb Co. and Sanofi-Aventis U.S. LLC that the suits fraudulently...To view the full article, register now.
Already a subscriber? Click here to view full article